Thyroid malignant tumors: epidemiology in our milieu

Authors

  • Yuri Medrano Plana Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Félix Manuel Becerra Cabanes Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • José Luis Llovera Rodríguez Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Mauricio Rafael Ortiz Vargas Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”
  • Ramón Bladimir Ramírez Cárdenas Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”
  • Sabrina Rebeca Santana Valencia Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”

Keywords:

thyroid neoplasms

Abstract

Carcinoma is the most frequent thyroid gland tumor and also the most frequent endocrine system malignancy. Thyroid cancer affects women more frequently than men, usually having an onset between ages 25 and 65 years. A study was performed including all cases with thyroid malignancy surgically treated in the Provincial University Hospital Arnaldo Milian Castro between January and December 2003. The incidence was 34.3%, with a female gender preference, with a peak at ages between 31 and 60 years. The main clinical symptom was cervical mass. Preoperatory ancillary tests were performed in order to help diagnosis and therapy (hemogram, cervical ultrasound and fine needle aspiration biopsy), being the last two procedures of utmost importance regarding the practical management. The treatment was surgical in all cases, with a total thyroidectomy in 75% of them. The 75% of cases were discharged successfully, with a hospitalization of less than 3 days.

Downloads

Download data is not yet available.

Author Biographies

Yuri Medrano Plana, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Residente de Cirugía General

Félix Manuel Becerra Cabanes, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I y II Grado en Cirugía General

José Luis Llovera Rodríguez, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Cirugía General

Mauricio Rafael Ortiz Vargas, Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”

Estudiante de Medicina

Ramón Bladimir Ramírez Cárdenas, Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”

Estudiante de Medicina

Sabrina Rebeca Santana Valencia, Instituto Superior de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”

Estudiante de Medicina

References

1. Saito T. Multiple endocrine neoplasia. Nippon Rinsho. 2004;62(5):962-6.

2. Jiménez C, Gagel RF. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2. Growth Horm IGF Res. 2004;14 Suppl A:150-7.

3. Hundahl SA, fleming ID, Fremgen AM. In: A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83(12):2638-48.

4. Khoo Ml, Asa SL, Witterick IJ. Thyroid calcification and its association with thyroid carcinoma. Head Neck. 2002;24(7):651-5.

5. Segovia IG, Gallowitsch Hj, Kresnik E, Kumnig G, Igerc I, Matschnig S, et al. Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria:1984-2001. Thyroid. 2004;14(4):227-86.

6. Iribarren C, Haselkorn T, Tekawa IS. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93(5):745-50.

7. Tie Y, Mao JP, Liu B, Song Y, Dong Y, Sun ZX. Effect of Papillary Thyroid Carcinoma Related Gene PTC1 on Subcellular Localization and Function of ATM Cell. Ai Zheng. 2004;23(5):487-92.

8. Fraker DL, Skarulis M, Livolsi V: Thyroid tumors. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1740-1762.

9. Rajesh L, Saha M, Radhika S, Das Radotra B, Rajwanshi A. Morphometric image analysis of follicular lesions of the thyroid. Anal Quant Cytol Histol. 2004;26(2):117-20.

10. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg. 1998;133(4):419-25.

11. Thyroid American Joint Committee on Cancer. In: AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002. p. 77-87.

12. Stephenson TJ. Papillary carcinoma of the thyroid: difficult yet fascinating model of oncogenesis and tumour progression. Pathology. 2004;44(5):498-500.

13. Guercioni G, Siquini W, Taccaliti A, Marmorale C. Surgical treatment of differentiated thyroid carcinoma. Ann Ital Chir. 2003;74(5):501-9.

14. Lennard CM, Patel A, Wilson J. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery. 2001;129(5):552-8.

15. Godballe C, Asschenfeldt P, Jorgensen KE. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope. 1998;108(2):243-9.

16. Voutilainen PE, Multanen MM, Leppäniemi AK. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid. 2001;11(10):953-7.

Downloads

How to Cite

1.
Medrano Plana Y, Becerra Cabanes FM, Llovera Rodríguez JL, Ortiz Vargas MR, Ramírez Cárdenas RB, Santana Valencia SR. Thyroid malignant tumors: epidemiology in our milieu. Acta Méd Centro [Internet]. 2007 May 1 [cited 2025 Jun. 28];1(1):10-6. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/313

Issue

Vol. 1 No. 1 (2007): May-August

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).